메뉴 건너뛰기




Volumn 48, Issue 8, 2013, Pages 1070-1076

CD34 + lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT

Author keywords

Allo SCT; AML; Chimerism; Minimal residual disease

Indexed keywords

AMSACRINE; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY; TREOSULFAN;

EID: 84881370213     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.2     Document Type: Article
Times cited : (45)

References (29)
  • 2
    • 80355129623 scopus 로고    scopus 로고
    • Long-Term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies
    • Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR et al. Long-Term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA 2011; 306: 1874-1883
    • (2011) JAMA , vol.306 , pp. 1874-1883
    • Sorror, M.L.1    Sandmaier, B.M.2    Storer, B.E.3    Franke, G.N.4    Laport, G.G.5    Chauncey, T.R.6
  • 3
    • 70350090181 scopus 로고    scopus 로고
    • Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A retrospective analysis
    • Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A retrospective analysis. Cancer 2009; 115: 4715-4726
    • (2009) Cancer , vol.115 , pp. 4715-4726
    • Gratwohl, A.1    Stern, M.2    Brand, R.3    Apperley, J.4    Baldomero, H.5    De Witte, T.6
  • 4
    • 27644494220 scopus 로고    scopus 로고
    • Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    • Stelljes M, Bornhauser M, Kroger M, Beyer J, Sauerland MC, Heinecke A et al. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Blood 2005; 106: 3314-3321
    • (2005) Blood , vol.106 , pp. 3314-3321
    • Stelljes, M.1    Bornhauser, M.2    Kroger, M.3    Beyer, J.4    Sauerland, M.C.5    Heinecke, A.6
  • 5
    • 79959959049 scopus 로고    scopus 로고
    • Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: Landmark analysis from a single prospective multicenter trial
    • Stelljes M, Beelen DW, Braess J, Sauerland MC, Heinecke A, Berning B et al. Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: Landmark analysis from a single prospective multicenter trial. Haematologica 2011; 96: 972-979
    • (2011) Haematologica , vol.96 , pp. 972-979
    • Stelljes, M.1    Beelen, D.W.2    Braess, J.3    Sauerland, M.C.4    Heinecke, A.5    Berning, B.6
  • 6
    • 69249221392 scopus 로고    scopus 로고
    • Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: Sustained regression before and after allogeneic stem cell transplantation
    • Metzelder S, Wang Y, Wollmer E, Wanzel M, Teichler S, Chaturvedi A et al. Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: Sustained regression before and after allogeneic stem cell transplantation. Blood 2009; 113: 6567-6571
    • (2009) Blood , vol.113 , pp. 6567-6571
    • Metzelder, S.1    Wang, Y.2    Wollmer, E.3    Wanzel, M.4    Teichler, S.5    Chaturvedi, A.6
  • 7
    • 84857999119 scopus 로고    scopus 로고
    • Azacitidine for treatment of imminent relapse in mds or aml patients after allogeneic hsct: Results of the relaza trial
    • Platzbecker U, Wermke M, Radke J, Oelschlaegel U, Seltmann F, Kiani A et al. Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: Results of the RELAZA trial. Leukemia 2012; 26: 381-389
    • (2012) Leukemia , vol.26 , pp. 381-389
    • Platzbecker, U.1    Wermke, M.2    Radke, J.3    Oelschlaegel, U.4    Seltmann, F.5    Kiani, A.6
  • 8
    • 84856857935 scopus 로고    scopus 로고
    • Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
    • Schmid C, Labopin M, Nagler A, Niederwieser D, Castagna L, Tabrizi R et al. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Blood 2012; 119: 1599-1606
    • (2012) Blood , vol.119 , pp. 1599-1606
    • Schmid, C.1    Labopin, M.2    Nagler, A.3    Niederwieser, D.4    Castagna, L.5    Tabrizi, R.6
  • 9
    • 0037370833 scopus 로고    scopus 로고
    • The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia
    • Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003; 101: 1698-1704
    • (2003) Blood , vol.101 , pp. 1698-1704
    • Ogawa, H.1    Tamaki, H.2    Ikegame, K.3    Soma, T.4    Kawakami, M.5    Tsuboi, A.6
  • 10
    • 37449023112 scopus 로고    scopus 로고
    • Monitoring of minimal residual disease in acute myeloid leukemia
    • Kern W, Haferlach C, Haferlach T, Schnittger S. Monitoring of minimal residual disease in acute myeloid leukemia. Cancer 2008; 112: 4-16
    • (2008) Cancer , vol.112 , pp. 4-16
    • Kern, W.1    Haferlach, C.2    Haferlach, T.3    Schnittger, S.4
  • 11
    • 80054717409 scopus 로고    scopus 로고
    • Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    • Dominietto A. Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Curr Opin Hematol 2011; 18: 381-387
    • (2011) Curr Opin Hematol , vol.18 , pp. 381-387
    • Dominietto, A.1
  • 12
    • 84855838173 scopus 로고    scopus 로고
    • Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
    • Buccisano F, Maurillo L, Del Principe MI, Del Poeta G, Sconocchia G, Lo-Coco F et al. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood 2012; 119: 332-341
    • (2012) Blood , vol.119 , pp. 332-341
    • Buccisano, F.1    Maurillo, L.2    Del Principe, M.I.3    Del Poeta, G.4    Sconocchia, G.5    Lo-Coco, F.6
  • 13
    • 19944386205 scopus 로고    scopus 로고
    • Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis
    • Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G et al. Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis. Leukemia 2004; 18: 2048-2050
    • (2004) Leukemia , vol.18 , pp. 2048-2050
    • Scheffold, C.1    Kroeger, M.2    Zuehlsdorf, M.3    Tchinda, J.4    Silling, G.5    Bisping, G.6
  • 14
    • 18644365146 scopus 로고    scopus 로고
    • Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation
    • Zeiser R, Spyridonidis A, Wasch R, Ihorst G, Grullich C, Bertz H et al. Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia 2005; 19: 814-821
    • (2005) Leukemia , vol.19 , pp. 814-821
    • Zeiser, R.1    Spyridonidis, A.2    Wasch, R.3    Ihorst, G.4    Grullich, C.5    Bertz, H.6
  • 15
    • 70449432763 scopus 로고    scopus 로고
    • Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
    • Bornhauser M, Oelschlaegel U, Platzbecker U, Bug G, Lutterbeck K, Kiehl MG et al. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation. Haematologica 2009; 94: 1613-1617
    • (2009) Haematologica , vol.94 , pp. 1613-1617
    • Bornhauser, M.1    Oelschlaegel, U.2    Platzbecker, U.3    Bug, G.4    Lutterbeck, K.5    Kiehl, M.G.6
  • 16
    • 0035195063 scopus 로고    scopus 로고
    • Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
    • Mattsson J, Uzunel M, Tammik L, Aschan J, Ringden O. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia 2001; 15: 1976-1985
    • (2001) Leukemia , vol.15 , pp. 1976-1985
    • Mattsson, J.1    Uzunel, M.2    Tammik, L.3    Aschan, J.4    Ringden, O.5
  • 17
    • 0033008061 scopus 로고    scopus 로고
    • Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
    • Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, Brendel C et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055-1060
    • (1999) Bone Marrow Transplant , vol.23 , pp. 1055-1060
    • Thiede, C.1    Florek, M.2    Bornhauser, M.3    Ritter, M.4    Mohr, B.5    Brendel, C.6
  • 18
    • 0035383779 scopus 로고    scopus 로고
    • High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (cancer and leukemia group b study 8361
    • Baer MR, Stewart CC, Dodge RK, Leget G, Sule N, Mrozek K et al. High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 2001; 97: 3574-3580
    • (2001) Blood , vol.97 , pp. 3574-3580
    • Baer, M.R.1    Stewart, C.C.2    Dodge, R.K.3    Leget, G.4    Sule, N.5    Mrozek, K.6
  • 22
    • 77449159028 scopus 로고    scopus 로고
    • Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet
    • Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453-474
    • (2010) Blood , vol.115 , pp. 453-474
    • Dohner, H.1    Estey, E.H.2    Amadori, S.3    Appelbaum, F.R.4    Buchner, T.5    Burnett, A.K.6
  • 24
    • 79960127726 scopus 로고    scopus 로고
    • Monitoring of minimal residual disease in npm1-mutated acute myeloid leukemia: A study from the german-Austrian acute myeloid leukemia study group
    • Kronke J, Schlenk RF, Jensen KO, Tschurtz F, Corbacioglu A, Gaidzik VI et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: A study from the German-Austrian acute myeloid leukemia study group. J Clin Oncol 2011; 29: 2709-2716
    • (2011) J Clin Oncol , vol.29 , pp. 2709-2716
    • Kronke, J.1    Schlenk, R.F.2    Jensen, K.O.3    Tschurtz, F.4    Corbacioglu, A.5    Gaidzik, V.I.6
  • 25
    • 79952439621 scopus 로고    scopus 로고
    • Monitoring of wt1 expression in pb and cd34(+) donor chimerism of bm predicts early relapse in aml and mds patients after hematopoietic cell transplantation with reduced-intensity conditioning
    • Lange T, Hubmann M, Burkhardt R, Franke GN, Cross M, Scholz M et al. Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning. Leukemia 2011; 25: 498-505
    • (2011) Leukemia , vol.25 , pp. 498-505
    • Lange, T.1    Hubmann, M.2    Burkhardt, R.3    Franke, G.N.4    Cross, M.5    Scholz, M.6
  • 26
    • 47649122245 scopus 로고    scopus 로고
    • Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): Comparison with WT1 gene expression
    • Barragan E, Pajuelo JC, Ballester S, Fuster O, Cervera J, Moscardo F et al. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): Comparison with WT1 gene expression. Clin Chim Acta 2008; 395: 120-123
    • (2008) Clin Chim Acta , vol.395 , pp. 120-123
    • Barragan, E.1    Pajuelo, J.C.2    Ballester, S.3    Fuster, O.4    Cervera, J.5    Moscardo, F.6
  • 27
    • 51349157656 scopus 로고    scopus 로고
    • Donor lymphocyte infusions for acute myeloid leukaemia best practice & research
    • Soiffer RJ. Donor lymphocyte infusions for acute myeloid leukaemia. Best practice & research. Clin haematoly 2008; 21: 455-466
    • (2008) Clin haematoly , vol.21 , pp. 455-466
    • Soiffer, R.J.1
  • 28
    • 81555228422 scopus 로고    scopus 로고
    • Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
    • Rettinger E, Willasch AM, Kreyenberg H, Borkhardt A, Holter W, Kremens B et al. Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation. Blood 2011; 118: 5681-5688
    • (2011) Blood , vol.118 , pp. 5681-5688
    • Rettinger, E.1    Willasch, A.M.2    Kreyenberg, H.3    Borkhardt, A.4    Holter, W.5    Kremens, B.6
  • 29
    • 78149413548 scopus 로고    scopus 로고
    • Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions
    • Sairafi D, Remberger M, Uhlin M, Ljungman P, Ringden O, Mattsson J. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions. Biol Blood Marrow Transplant 2010; 16: 1728-1737
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1728-1737
    • Sairafi, D.1    Remberger, M.2    Uhlin, M.3    Ljungman, P.4    Ringden, O.5    Mattsson, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.